Author:
de Medeiros Vieira Amanda Carla Quintas,Marques Graziella Silvestre,de Melo Cybelly Marques,da Silva Keyla Emanuelle Ramos,Rolim Larissa Araújo,do Carmo Alves de Lima Maria,Galdino Suely Lins,da Rocha Pitta Ivan,Neto Pedro José Rolim
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Liesen AP, Aquino TM, Góes AJS, Lima JG, Faria AR, Alves AJ. Métodos de obtenção, reatividade e importância biológica de 4-tiazolidinonas. Quím Nova. 2008;31:369–76.
2. Buckingham RE. Thiazolidinediones: Pleiotropic drugs with potent anti-inflammatory properties for tissue protection. Hepatol Res. 2005. doi: 10.1016/j.hepres.2005.09.027 .
3. Barnett AH. Redefining the role of thiazolidinediones in the management of type 2 diabetes. Vasc Health Risk Manag. 2009;5:141–51.
4. Chen SD, Wu HY, Yang DI, Lee SY, Shaw FZ, Lin TK, Liou CW, Chuang YC. Effects of rosiglitazone on global ischemia-induced hippocampal injury and expression of mitochondrial uncoupling protein 2. Biochem Biophys Res Commun. 2006;351:198–203.
5. Luo Y, Yin W, Signore AP, Zhang F, Hong Z, Wang S, Graham SH, Chen J. Neuroprotection against focal ischemic brain injury by the peroxisomes proliferators-activated receptor-γ agonist rosiglitazone. J Neurochem. 2006;97:435–48.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献